/
Hartford Creative Group, Inc. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. On May 11, 2024, the Company further changed its name to Hartford Creative Group, Inc.
$4.00
+$0.00 (+0.00%)
EOD Jul 17, 2026
Margins and capital returns are both well above average: 60.20% operating margin, ROIC at 675.35%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 45.4%, still solid. Margins contracted 18.1pp, which offsets some of the top-line progress.
At 100x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 102% versus the prior year, cash generation momentum has weakened.
100.0x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (FY)
$2M
▲ +45.4% YoY
Net Income (TTM)
$1M
▲ +0.6% YoY
Op. Margin
60.20%
▼ -18.1pp YoY
ROIC
278.19%
▼ -29243.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$477K
▼ -101.6% YoY
Op. Cash Flow (TTM)
-$477K
▼ -101.5% YoY
Net Debt
-$160K
Net Cash Position
Cash & Equiv.
$160K
5Y CAGR: +105.0%
Continue Research
At a P/E of 100.0, Hartford Great Health (HFUS)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Hartford Great Health scores 60/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Hartford Great Health scores 60 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 60.2% operating margin and a 278.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh HFUS's valuation and scores 60/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.